Andrew Hill Investment Advisors reports that client portfolios achieved double digit gains during 2025. Review our defensive ...

Alphabet’s AI-driven Google Cloud has transformed from a loss-making unit into a high-margin, cash-generating growth engine.

Paired with a cheap dual PEG16X boards like the Asrock 939SLI32-eSATA2, dual graphics with Chrome S27s is doable for under ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without regular ...

After following XYZ Laboratories recent expansion in the news, I was pleased to see your advertisement for an analytical chemist (position 35872), in the August 7 issue of Chemical and Engineering ...

As a former claims handler and fraud investigator, Jason Metz has worked on a multitude of complex and multifaceted claims. The insurance industry can be seemingly opaque, and Jason enjoys breaking ...

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling ...